Autosomal Dominant Hypocalcemia
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Autosomal Dominant Hypocalcemia

What is the definition of Autosomal Dominant Hypocalcemia?

Autosomal dominant hypocalcemia is characterized by low levels of calcium in the blood (hypocalcemia). Affected individuals can have an imbalance of other molecules in the blood as well, including too much phosphate (hyperphosphatemia) or too little magnesium (hypomagnesemia). Some people with autosomal dominant hypocalcemia also have low levels of a hormone called parathyroid hormone (hypoparathyroidism). This hormone is involved in the regulation of calcium levels in the blood. Abnormal levels of calcium and other molecules in the body can lead to a variety of signs and symptoms, although about half of affected individuals have no associated health problems.

What are the causes of Autosomal Dominant Hypocalcemia?

Autosomal dominant hypocalcemia is primarily caused by mutations in the CASR gene; these cases are known as type 1. A small percentage of cases, known as type 2, are caused by mutations in the GNA11 gene. The proteins produced from these genes work together to regulate the amount of calcium in the blood.

How prevalent is Autosomal Dominant Hypocalcemia?

The prevalence of autosomal dominant hypocalcemia is unknown. The condition is likely underdiagnosed because it often causes no signs or symptoms.

Is Autosomal Dominant Hypocalcemia an inherited disorder?

This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.

Who are the top Autosomal Dominant Hypocalcemia Local Doctors?
Elite in Autosomal Dominant Hypocalcemia
Elite in Autosomal Dominant Hypocalcemia
Referral may be required
Oxford, ENG, GB 

Fadil Hannan practices practicing medicine in Oxford, United Kingdom. Mr. Hannan is rated as an Elite expert by MediFind in the treatment of Autosomal Dominant Hypocalcemia. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Milk-Alkali Syndrome, Hypercalcemia, Autosomal Dominant Hypocalcemia, and Familial Hypocalciuric Hypercalcemia Type 1.

Elite in Autosomal Dominant Hypocalcemia
Pediatric Endocrinology
Elite in Autosomal Dominant Hypocalcemia
Pediatric Endocrinology
Referral may be required

Office

30 Rockville Pike, 
Bethesda, MD 
Languages Spoken:
English
Accepting New Patients

Rachel Gafni is a Pediatric Endocrinologist practicing medicine in Bethesda, Maryland. Dr. Gafni is rated as an Elite provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Autosomal Dominant Hypocalcemia, Osteomalacia, Osteitis Fibrosa, Malnutrition, and Hormone Replacement Therapy (HRT). Dr. Gafni is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Autosomal Dominant Hypocalcemia
Elite in Autosomal Dominant Hypocalcemia
Referral may be required
Edgbaston, ENG, GB 

Caroline Gorvin practices practicing medicine in Edgbaston, United Kingdom. Ms. Gorvin is rated as an Elite expert by MediFind in the treatment of Autosomal Dominant Hypocalcemia. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Milk-Alkali Syndrome, Hypercalcemia, Autosomal Dominant Hypocalcemia, and Familial Hypocalciuric Hypercalcemia Type 1.

What are the latest Autosomal Dominant Hypocalcemia Clinical Trials?
A Phase 2/3, Multicenter, Single-Arm, Open-Label Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)

Summary: The overall objective of this study is to evaluate the pharmacokinetics (PK), efficacy, and safety of encaleret in pediatric participants from birth to 17 years of age with ADH1.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: February 01, 2015
Published By: National Institutes of Health